glp 1 mechanism of action weight loss Frontiers GLP-1 and health: Beyond weight

TPO and TG Ab typically appear to have no adverse effect

The Rationale for Dual Targeting The concept of dual GIP/GLP-1 receptor agonism emerged from observations that patients with type 2 diabetes often exhibit reduced GIP sensitivity, while GLP-1 responses may remain relatively preserved

On the other hand, directly stimulating GLP-1R in brain regions that send signals through the vagus nerve is enough to trigger reduced locomotor activity, offering practical evidence for a microbiome-GLP-1-vagal pathway in the regulation of neurobehavior [123,125]

Ozempic is approved for type 2 diabetes at doses up to 2 mg weekly

Blood levels are building but have not reached steady state